Sign In
Buy IMGN
$31.23
+0 (+0%)
At Close: May 08, 2024
AbbVie to Acquire ImmunoGen in $10 Billion Deal
08:18am, Thursday, 30'th Nov 2023
AbbVie will acquire all outstanding shares of ImmunoGen for $31.26 a share.
AbbVie to buy ImmunoGen for $10.1 billion to boost cancer drug portfolio
07:46am, Thursday, 30'th Nov 2023
AbbVie said on Thursday it will buy drugmaker ImmunoGen for $10.1 billion, boosting its presence in the market for cancer treatments.
AbbVie $10.1 billion deal to buy ImmunoGen values the stock at a 95% premium
07:43am, Thursday, 30'th Nov 2023
AbbVie Inc. ABBV, +0.30% announced Thursday an agreement to buy cancer treatment developer ImmunoGen Inc. IMGN, +0.50% in a cash deal valued at $10.1 billion. Under terms of the agreement, AbbVie will
New Strong Buy Stocks for November 29th
08:16am, Wednesday, 29'th Nov 2023
TM, PAY, WRB, MNDY and IMGN have been added to the Zacks Rank #1 (Strong Buy) List on November 29, 2023.
ImmunoGen: Elahere Data Mid-2024 To Expand Targeted Population
05:41pm, Monday, 27'th Nov 2023
ImmunoGen, Inc. expects to convert the Accelerated Approval of its drug Elahere to "Full Approval" in the 1st half of 2024. Potential European approval of Elahere for treatment of patients with FRa-hi
Wall Street Analysts Believe ImmunoGen (IMGN) Could Rally 52.99%: Here's is How to Trade
11:17am, Wednesday, 22'nd Nov 2023
The mean of analysts' price targets for ImmunoGen (IMGN) points to a 53% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:32am, Wednesday, 22'nd Nov 2023
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
New Strong Buy Stocks for November 22nd
07:31am, Wednesday, 22'nd Nov 2023
RIGL, BWAY, AVDX, IMGN and EAT have been added to the Zacks Rank #1 (Strong Buy) List on November 22, 2023.
Best Momentum Stocks to Buy for November 16th
11:16am, Thursday, 16'th Nov 2023
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 16, 2023.:
New Strong Buy Stocks for November 16th
08:16am, Thursday, 16'th Nov 2023
IMGN, AQST, BUR, GWRE and VECO have been added to the Zacks Rank #1 (Strong Buy) List on November 16, 2023.
ImmunoGen (IMGN) Just Overtook the 20-Day Moving Average
11:18am, Wednesday, 15'th Nov 2023
After reaching an important support level, ImmunoGen (IMGN) could be a good stock pick from a technical perspective. IMGN surpassed resistance at the 20-day moving average, suggesting a short-term bul
4 Stocks to Invest in for Remarkable Earnings Acceleration
08:16am, Tuesday, 07'th Nov 2023
Invest in stocks such as Confluent (CFLT), Pinterest (PINS), ICON (ICLR) and ImmunoGen (IMGN) for solid earnings acceleration.
Wall Street Analysts See a 40.58% Upside in ImmunoGen (IMGN): Can the Stock Really Move This High?
11:17am, Monday, 06'th Nov 2023
The consensus price target hints at a 40.6% upside potential for ImmunoGen (IMGN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimat
ImmunoGen (IMGN) Q3 Earnings Beat, Elahere Drives Revenues
01:32pm, Friday, 03'rd Nov 2023
ImmunoGen's (IMGN) third-quarter 2023 earnings and revenues surpass estimates, driven by strong adoption of its sole-marketed drug Elahere. The company reiterates its revenue guidance.
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies London Healthcare Conference
04:30pm, Thursday, 02'nd Nov 2023
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will p
